Stock & Company Details
CRISPR Therapeutics AG $CRSP
Price:
N/A
N/A
97M
$4.9B
52 Week High:
N/A
10 Day Average Volume:
N/A
-8.12
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
CRSP technical indicators
Latest CRISPR Therapeutics AG (CRSP) indicator readings as of 2026-10-09.
CRSP's 14-day RSI is 46.7, in neutral territory. At $53.39 it is trading 0.3% above its 200-day moving average of $53.23, and below its 50-day average of $54.99. Price sits in the middle of its Bollinger Bands ($50.46 to $59.31). ADX reads 18.4, indicating a range-bound market rather than a trend.
Overview
CRISPR Therapeutics is a gene editing company focused on the development of CRISPR/Cas9-based therapeutics. CRISPR/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. CRISPR's most advanced pipeline candidate, exa-cel, is in collaboration with Vertex Pharmaceuticals and targets sickle cell disease and transfusion-dependent beta-thalassemia, which have high unmet medical needs. The company is progressing additional gene editing programs for immuno-oncology, as well as a stem cell-derived therapy for the treatment of Type 1 diabetes.
Finance Bot
Ask your questions
Start by typing a question below.
